Location: Home
  • search
  • go
  • Relate News
  • 5/6/2009Chinese expert call for standardized therapy for asthma
  • 5/5/2009Cuban diabetes drug Heberprot-B under registration in China
  • 5/5/2009WuXi PharmaTech appoints new VP of finance
  • 5/5/2009Pharma companies turn to Chinese OTC healthcare market for higher retu...
  • 5/5/2009Novartis sponsors large scale nationwide hypertension survey
  • 5/4/2009In-depth Analysis of Hospital Market Shares of MNC pharma companies 20...
  • 5/4/2009SMEI: Projections of Chinese drug market size and segmentation in 2008...
  • 5/4/2009SFDA Deputy Commissioner calls for stringent drug regulation
  • 5/4/2009Public comments sought for the 2010 Edition of Chinese Pharmacopoeia ...
  • 5/1/2009CIRC to introduce policies for healthcare reform participation by comm...
  • 5/1/2009Nicholas Hall: China’s OTC eye drops market rose 9% last year
  • 5/1/2009IBM opens healthare industry solution lab in Beijing
  • 5/1/2009Chinese scientists develop live H5N1 vaccine for human
  • 5/1/2009IMS: 2008 Overview of China Pharmaceutical Market (MAT4Q/08)
  • 5/1/2009IFPMA in the process of leadership transition
  • 4/30/2009Sinovac eyes development of swine flu vaccine
  • 4/30/2009China has at least 100 million patients of mental illnesses
  • 4/30/2009NIAID/NIH and Henan DOH cooperates on tuberculosis research
  • 4/30/2009Chinese antiviral drug producers anticipate rising demands
  • 4/30/2009China Pharma Holdings makes new appointments
  • 4/30/2009BioVeda likely to establish biopharma fund of CNY 1-2 billion in Guang...
  • 4/30/2009Novozymes builds new cGMP facility in Tianjin
  • 4/28/2009Jiangsu Hengrui to set up R&D subsidiary in Sweden
  • 4/28/2009Latest physician survey reveals aggravations of Chinese doctors
  • 4/28/2009Recent exchanges between CDE/SFDA, PhRMA and USFDA
  • 4/27/2009Alnylam Pharma to receive new patent for RNAs
  • 4/27/2009GSK Biological seeks to expand vaccine business in China
  • 4/27/2009SFDA to promote the consolidation in pharma sector
  • 4/27/2009Phase I trials of class one oncology drug Ethaselen initiated
  • 4/27/2009J&JPRD appoints head of R&D center in Shanghai
  • Page:678/790 Total number of articles:23675: [First][<<] [676] [677] [678] [679] [680] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group